RADIOTERAPIA Y CIRUGÍA COMO TRATAMIENTO INTEGRADO EN ADENOCARCINOMA DE ENDOMETRIO ESTADIO II-B

SUMMARY OBJECTIVE: The objective of these work was the evaluated of the statistics difference between global survive and interval free disease in patients with endometrial carcinoma classified how stage II B, treated in the gynecological service of the “Padre Machado” Hospital, one of the patients treated with radiotherapy before surgery and the other treated with radiotherapy after the surgery. METHODS: We included 23 patients with endometrial carcinoma stage IIB seen and treated between 1990- 2001, to 15 of the patients were tried with surgery plus external radiotherapy and 8 of the patients with radiotherapy and brachytherapy before the surgery. The surgical procedures performed for the two groups were the nominated “endometrial protocol”. RESULTS: The common age was 60 years. The group with radiotherapy postoperative received a promedial dose of 50 Gy, and the group with preoperative radiotherapy received a dose of 70 Gy. The tease of recurrence and global survive was of 20 % and 86.67 % respectively in patients with surgery as primary treatment, in compare with 12.5% and 87.5 % of the patients with radiotherapy preoperative. CONCLUSION: There is not any significant statistic in relation to interval free disease survival and to the global survival between the both groups.